Cargando…
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus
BACKGROUND: High costs of direct-acting antivirals (DAAs) have led health-care insurers to limit access worldwide. Using a natural experiment, we evaluated the impact of removing fibrosis stage restrictions on hepatitis C (HCV) treatment initiation rates among people living with human immunodeficien...
Autores principales: | Saeed, Sahar, Strumpf, Erin, Moodie, Erica E M, Wong, Leo, Cox, Joseph, Walmsley, Sharon, Tyndall, Mark, Cooper, Curtis, Conway, Brian, Hull, Mark, Martel-Laferriere, Valerie, Gill, John, Wong, Alexander, Vachon, Marie-Louise, Klein, Marina B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353326/ https://www.ncbi.nlm.nih.gov/pubmed/31504327 http://dx.doi.org/10.1093/cid/ciz833 |
Ejemplares similares
-
Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada
por: Saeed, Sahar, et al.
Publicado: (2017) -
Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients
por: Rossi, Carmine, et al.
Publicado: (2018) -
Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV‐HCV co‐infected patients in Canada
por: Kronfli, Nadine, et al.
Publicado: (2018) -
Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study
por: Martel-Laferrière, Valérie, et al.
Publicado: (2017) -
Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning
por: Marathe, Gayatri, et al.
Publicado: (2022)